China Human Milk eOligosaccharids (HMO) Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Human Milk eOligosaccharids (HMO) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Dextra Laboratories

    • ZuChem

    • Jennewein Biotechnologie

    • Glycom

    • Inbiose

    By Type:

    • Acidic

    • Other

    • Neutral

    By Application:

    • Food supplements

    • Others

    • Infant formula

    • Functional food & beverages

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Human Milk eOligosaccharids (HMO) Market Overview 2018-2029

    • 1.1 China Human Milk eOligosaccharids (HMO) Industry Development Overview

    • 1.2 China Human Milk eOligosaccharids (HMO) Industry Development History

    • 1.3 China Human Milk eOligosaccharids (HMO) Industry Market Size (2018-2029)

    • 1.4 China Human Milk eOligosaccharids (HMO) Market Analysis by Type from Production Side

      • 1.4.1 China Human Milk eOligosaccharids (HMO) Production Volume, Production Value and Growth Rate of Acidic (2018-2029)

      • 1.4.2 China Human Milk eOligosaccharids (HMO) Production Volume, Production Value and Growth Rate of Other (2018-2029)

      • 1.4.3 China Human Milk eOligosaccharids (HMO) Production Volume, Production Value and Growth Rate of Neutral (2018-2029)

    • 1.5 China Human Milk eOligosaccharids (HMO) Market Analysis by Application from Consumption End

      • 1.5.1 China Human Milk eOligosaccharids (HMO) Sales Volume, Sales Value and Growth Rate of Food supplements (2018-2029)

      • 1.5.2 China Human Milk eOligosaccharids (HMO) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Human Milk eOligosaccharids (HMO) Sales Volume, Sales Value and Growth Rate of Infant formula (2018-2029)

      • 1.5.4 China Human Milk eOligosaccharids (HMO) Sales Volume, Sales Value and Growth Rate of Functional food & beverages (2018-2029)

    • 1.6 China Human Milk eOligosaccharids (HMO) Market Analysis by Region

      • 1.6.1 North China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Human Milk eOligosaccharids (HMO) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Human Milk eOligosaccharids (HMO) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Human Milk eOligosaccharids (HMO) Market Status and Competition Analysis in 2023

      • 2.2.3 China Human Milk eOligosaccharids (HMO) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Human Milk eOligosaccharids (HMO) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Human Milk eOligosaccharids (HMO) Industry Development

    Chapter 3 Human Milk eOligosaccharids (HMO)Industry Chain Analysis

    • 3.1 Human Milk eOligosaccharids (HMO) Industry Chain

    • 3.2 Human Milk eOligosaccharids (HMO) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Human Milk eOligosaccharids (HMO) Market

    • 3.3 Human Milk eOligosaccharids (HMO) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Human Milk eOligosaccharids (HMO) Market

    Chapter 4 China Human Milk eOligosaccharids (HMO) Market, by Type

    • 4.1 China Human Milk eOligosaccharids (HMO) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Human Milk eOligosaccharids (HMO) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Human Milk eOligosaccharids (HMO) Production Volume and Growth Rate, by Type

      • 4.5.1 China Human Milk eOligosaccharids (HMO) Production Volume and Growth Rate of Acidic

      • 4.5.2 China Human Milk eOligosaccharids (HMO) Production Volume and Growth Rate of Other

      • 4.5.3 China Human Milk eOligosaccharids (HMO) Production Volume and Growth Rate of Neutral

    Chapter 5 China Human Milk eOligosaccharids (HMO) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Human Milk eOligosaccharids (HMO) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate, by Application

      • 5.5.1 China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate of Food supplements

      • 5.5.2 China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate of Others

      • 5.5.3 China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate of Infant formula

      • 5.5.4 China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate of Functional food & beverages

    Chapter 6 China Human Milk eOligosaccharids (HMO) Market, by Region

    • 6.1 China Human Milk eOligosaccharids (HMO) Production Volume and Production Value, by Region

    • 6.2 China Human Milk eOligosaccharids (HMO) Sales Volume and Sales Value, by Region

    Chapter 7 North China Human Milk eOligosaccharids (HMO) Market Analysis

    • 7.1 North China Human Milk eOligosaccharids (HMO) Market, by Type

    • 7.2 North China Human Milk eOligosaccharids (HMO) Market, by Application

    Chapter 8 Central China Human Milk eOligosaccharids (HMO) Market Analysis

    • 8.1 Central China Human Milk eOligosaccharids (HMO) Market, by Type

    • 8.2 Central China Human Milk eOligosaccharids (HMO) Market, by Application

    Chapter 9 South China Human Milk eOligosaccharids (HMO) Market Analysis

    • 9.1 South China Human Milk eOligosaccharids (HMO) Market, by Type

    • 9.2 South China Human Milk eOligosaccharids (HMO) Market, by Application

    Chapter 10 East China Human Milk eOligosaccharids (HMO) Market Analysis

    • 10.1 East China Human Milk eOligosaccharids (HMO) Market, by Type

    • 10.2 East China Human Milk eOligosaccharids (HMO) Market, by Application

    Chapter 11 Northeast China Human Milk eOligosaccharids (HMO) Market Analysis

    • 11.1 Northeast China Human Milk eOligosaccharids (HMO) Market, by Type

    • 11.2 Northeast China Human Milk eOligosaccharids (HMO) Market, by Application

    Chapter 12 Southwest China Human Milk eOligosaccharids (HMO) Market Analysis

    • 12.1 Southwest China Human Milk eOligosaccharids (HMO) Market, by Type

    • 12.2 Southwest China Human Milk eOligosaccharids (HMO) Market, by Application

    Chapter 13 Northwest China Human Milk eOligosaccharids (HMO) Market Analysis

    • 13.1 Northwest China Human Milk eOligosaccharids (HMO) Market, by Type

    • 13.2 Northwest China Human Milk eOligosaccharids (HMO) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Dextra Laboratories

        • 14.1.1 Dextra Laboratories Company Profile

        • 14.1.2 Dextra Laboratories Human Milk eOligosaccharids (HMO) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 ZuChem

        • 14.2.1 ZuChem Company Profile

        • 14.2.2 ZuChem Human Milk eOligosaccharids (HMO) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Jennewein Biotechnologie

        • 14.3.1 Jennewein Biotechnologie Company Profile

        • 14.3.2 Jennewein Biotechnologie Human Milk eOligosaccharids (HMO) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Glycom

        • 14.4.1 Glycom Company Profile

        • 14.4.2 Glycom Human Milk eOligosaccharids (HMO) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Inbiose

        • 14.5.1 Inbiose Company Profile

        • 14.5.2 Inbiose Human Milk eOligosaccharids (HMO) Market Performance

        • 14.5.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Human Milk eOligosaccharids (HMO) Industry Research Conclusions

    • 15.2 Human Milk eOligosaccharids (HMO) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Human Milk eOligosaccharids (HMO) Industry Market Size (2018-2029)

    • Figure China Human Milk eOligosaccharids (HMO) Production Volume, Production Value and Growth Rate of Acidic (2018-2029)

    • Figure China Human Milk eOligosaccharids (HMO) Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • Figure China Human Milk eOligosaccharids (HMO) Production Volume, Production Value and Growth Rate of Neutral (2018-2029)

    • Figure China Human Milk eOligosaccharids (HMO) Sales Volume, Sales Value and Growth Rate of Food supplements (2018-2029)

    • Figure China Human Milk eOligosaccharids (HMO) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Human Milk eOligosaccharids (HMO) Sales Volume, Sales Value and Growth Rate of Infant formula (2018-2029)

    • Figure China Human Milk eOligosaccharids (HMO) Sales Volume, Sales Value and Growth Rate of Functional food & beverages (2018-2029)

    • Figure North China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate from 2018-2029

    • Figure Central China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate from 2018-2029

    • Figure South China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate from 2018-2029

    • Figure East China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate from 2018-2029

    • Figure Human Milk eOligosaccharids (HMO) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Human Milk eOligosaccharids (HMO) Market Share by Type in 2018

    • Figure China Human Milk eOligosaccharids (HMO) Market Share by Type in 2023

    • Figure China Human Milk eOligosaccharids (HMO) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Human Milk eOligosaccharids (HMO) Production Volume and Growth Rate of Acidic (2018-2023)

    • Figure China Human Milk eOligosaccharids (HMO) Production Volume and Growth Rate of Other (2018-2023)

    • Figure China Human Milk eOligosaccharids (HMO) Production Volume and Growth Rate of Neutral (2018-2023)

    • Figure China Human Milk eOligosaccharids (HMO) Market Share by Application in 2018

    • Figure China Human Milk eOligosaccharids (HMO) Market Share by Application in 2023

    • Figure China Human Milk eOligosaccharids (HMO) Total Market Size and Growth Rate from Consumption End

    • Figure China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate of Food supplements (2018-2023)

    • Figure China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate of Others (2018-2023)

    • Figure China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate of Infant formula (2018-2023)

    • Figure China Human Milk eOligosaccharids (HMO) Market Size and Growth Rate of Functional food & beverages (2018-2023)

    • Table China Human Milk eOligosaccharids (HMO) Production Volume by Region (2018-2023)

    • Table China Human Milk eOligosaccharids (HMO) Production Volume Share by Region (2018-2023)

    • Figure China Human Milk eOligosaccharids (HMO) Production Volume Share by Region (2018-2023)

    • Table China Human Milk eOligosaccharids (HMO) Production Value by Region (2018-2023)

    • Table China Human Milk eOligosaccharids (HMO) Production Value Share by Region (2018-2023)

    • Figure China Human Milk eOligosaccharids (HMO) Production Value Share by Region (2018-2023)

    • Table China Human Milk eOligosaccharids (HMO) Sales Volume by Region (2018-2023)

    • Table China Human Milk eOligosaccharids (HMO) Sales Volume Share by Region (2018-2023)

    • Figure China Human Milk eOligosaccharids (HMO) Sales Volume Share by Region (2018-2023)

    • Table China Human Milk eOligosaccharids (HMO) Sales Value by Region (2018-2023)

    • Table China Human Milk eOligosaccharids (HMO) Sales Value Share by Region (2018-2023)

    • Figure China Human Milk eOligosaccharids (HMO) Sales Value Share by Region (2018-2023)

    • Table North China Human Milk eOligosaccharids (HMO) Production Volume by Type (2018-2023)

    • Table North China Human Milk eOligosaccharids (HMO) Production Volume Share by Type (2018-2023)

    • Figure North China Human Milk eOligosaccharids (HMO) Production Volume Share by Type (2018-2023)

    • Table North China Human Milk eOligosaccharids (HMO) Sales Volume by Application (2018-2023)

    • Table North China Human Milk eOligosaccharids (HMO) Sales Volume Share by Application (2018-2023)

    • Figure North China Human Milk eOligosaccharids (HMO) Sales Volume Share by Application (2018-2023)

    • Table Central China Human Milk eOligosaccharids (HMO) Production Volume by Type (2018-2023)

    • Table Central China Human Milk eOligosaccharids (HMO) Production Volume Share by Type (2018-2023)

    • Figure Central China Human Milk eOligosaccharids (HMO) Production Volume Share by Type (2018-2023)

    • Table Central China Human Milk eOligosaccharids (HMO) Sales Volume by Application (2018-2023)

    • Table Central China Human Milk eOligosaccharids (HMO) Sales Volume Share by Application (2018-2023)

    • Figure Central China Human Milk eOligosaccharids (HMO) Sales Volume Share by Application (2018-2023)

    • Table South China Human Milk eOligosaccharids (HMO) Production Volume by Type (2018-2023)

    • Table South China Human Milk eOligosaccharids (HMO) Production Volume Share by Type (2018-2023)

    • Figure South China Human Milk eOligosaccharids (HMO) Production Volume Share by Type (2018-2023)

    • Table South China Human Milk eOligosaccharids (HMO) Sales Volume by Application (2018-2023)

    • Table South China Human Milk eOligosaccharids (HMO) Sales Volume Share by Application (2018-2023)

    • Figure South China Human Milk eOligosaccharids (HMO) Sales Volume Share by Application (2018-2023)

    • Table East China Human Milk eOligosaccharids (HMO) Production Volume by Type (2018-2023)

    • Table East China Human Milk eOligosaccharids (HMO) Production Volume Share by Type (2018-2023)

    • Figure East China Human Milk eOligosaccharids (HMO) Production Volume Share by Type (2018-2023)

    • Table East China Human Milk eOligosaccharids (HMO) Sales Volume by Application (2018-2023)

    • Table East China Human Milk eOligosaccharids (HMO) Sales Volume Share by Application (2018-2023)

    • Figure East China Human Milk eOligosaccharids (HMO) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Human Milk eOligosaccharids (HMO) Production Volume by Type (2018-2023)

    • Table Northeast China Human Milk eOligosaccharids (HMO) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Human Milk eOligosaccharids (HMO) Production Volume Share by Type (2018-2023)

    • Table Northeast China Human Milk eOligosaccharids (HMO) Sales Volume by Application (2018-2023)

    • Table Northeast China Human Milk eOligosaccharids (HMO) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Human Milk eOligosaccharids (HMO) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Human Milk eOligosaccharids (HMO) Production Volume by Type (2018-2023)

    • Table Southwest China Human Milk eOligosaccharids (HMO) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Human Milk eOligosaccharids (HMO) Production Volume Share by Type (2018-2023)

    • Table Southwest China Human Milk eOligosaccharids (HMO) Sales Volume by Application (2018-2023)

    • Table Southwest China Human Milk eOligosaccharids (HMO) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Human Milk eOligosaccharids (HMO) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Human Milk eOligosaccharids (HMO) Production Volume by Type (2018-2023)

    • Table Northwest China Human Milk eOligosaccharids (HMO) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Human Milk eOligosaccharids (HMO) Production Volume Share by Type (2018-2023)

    • Table Northwest China Human Milk eOligosaccharids (HMO) Sales Volume by Application (2018-2023)

    • Table Northwest China Human Milk eOligosaccharids (HMO) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Human Milk eOligosaccharids (HMO) Sales Volume Share by Application (2018-2023)

    • Table Dextra Laboratories Company Profile

    • Table Dextra Laboratories Human Milk eOligosaccharids (HMO) Revenue, Price and Gross (2018-2023)

    • Table ZuChem Company Profile

    • Table ZuChem Human Milk eOligosaccharids (HMO) Revenue, Price and Gross (2018-2023)

    • Table Jennewein Biotechnologie Company Profile

    • Table Jennewein Biotechnologie Human Milk eOligosaccharids (HMO) Revenue, Price and Gross (2018-2023)

    • Table Glycom Company Profile

    • Table Glycom Human Milk eOligosaccharids (HMO) Revenue, Price and Gross (2018-2023)

    • Table Inbiose Company Profile

    • Table Inbiose Human Milk eOligosaccharids (HMO) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.